{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T21:13:02Z","timestamp":1779916382133,"version":"3.53.1"},"reference-count":55,"publisher":"Portland Press Ltd.","issue":"22","license":[{"start":{"date-parts":[[2022,11,4]],"date-time":"2022-11-04T00:00:00Z","timestamp":1667520000000},"content-version":"vor","delay-in-days":3,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,11,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Cardiac hypertrophy is necessary for the heart to accommodate an increase in workload. Physiological, compensated hypertrophy (e.g. with exercise) is reversible and largely due to cardiomyocyte hypertrophy. Pathological hypertrophy (e.g. with hypertension) is associated with additional features including increased fibrosis and can lead to heart failure. RAF kinases (ARAF\/BRAF\/RAF1) integrate signals into the extracellular signal-regulated kinase 1\/2 cascade, a pathway implicated in cardiac hypertrophy, and activation of BRAF in cardiomyocytes promotes compensated hypertrophy. Here, we used mice with tamoxifen-inducible cardiomyocyte-specific BRAF knockout (CM-BRAFKO) to assess the role of BRAF in hypertension-associated cardiac hypertrophy induced by angiotensin II (AngII; 0.8 mg\/kg\/d, 7 d) and physiological hypertrophy induced by phenylephrine (40 mg\/kg\/d, 7 d). Cardiac dimensions\/functions were measured by echocardiography with histological assessment of cellular changes. AngII promoted cardiomyocyte hypertrophy and increased fibrosis within the myocardium (interstitial) and around the arterioles (perivascular) in male mice; cardiomyocyte hypertrophy and interstitial (but not perivascular) fibrosis were inhibited in mice with CM-BRAFKO. Phenylephrine had a limited effect on fibrosis but promoted cardiomyocyte hypertrophy and increased contractility in male mice; cardiomyocyte hypertrophy was unaffected in mice with CM-BRAFKO, but the increase in contractility was suppressed and fibrosis increased. Phenylephrine induced a modest hypertrophic response in female mice and, in contrast with the males, tamoxifen-induced loss of cardiomyocyte BRAF reduced cardiomyocyte size, had no effect on fibrosis and increased contractility. The data identify BRAF as a key signalling intermediate in both physiological and pathological hypertrophy in male mice, and highlight the need for independent assessment of gene function in females.<\/jats:p>","DOI":"10.1042\/cs20220607","type":"journal-article","created":{"date-parts":[[2022,11,4]],"date-time":"2022-11-04T07:08:14Z","timestamp":1667545694000},"page":"1661-1681","update-policy":"https:\/\/doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Cardiomyocyte BRAF is a key signalling intermediate in cardiac hypertrophy in mice"],"prefix":"10.1042","volume":"136","author":[{"given":"Hajed\u00a0O.","family":"Alharbi","sequence":"first","affiliation":[{"name":"1School of Biological Sciences, University of Reading, Reading, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle\u00a0A.","family":"Hardyman","sequence":"additional","affiliation":[{"name":"1School of Biological Sciences, University of Reading, Reading, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua\u00a0J.","family":"Cull","sequence":"additional","affiliation":[{"name":"1School of Biological Sciences, University of Reading, Reading, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomais","family":"Markou","sequence":"additional","affiliation":[{"name":"1School of Biological Sciences, University of Reading, Reading, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna\u00a0T.E.","family":"Cooper","sequence":"additional","affiliation":[{"name":"2Molecular and Clinical Sciences Institute, St. George\u2019s University of London, London, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter\u00a0E.","family":"Glennon","sequence":"additional","affiliation":[{"name":"3University Hospitals Coventry and Warwickshire, University Hospital Cardiology Department, Clifford Bridge Road, Coventry, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen\u00a0J.","family":"Fuller","sequence":"additional","affiliation":[{"name":"1School of Biological Sciences, University of Reading, Reading, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter\u00a0H.","family":"Sugden","sequence":"additional","affiliation":[{"name":"1School of Biological Sciences, University of Reading, Reading, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5658-0708","authenticated-orcid":false,"given":"Angela","family":"Clerk","sequence":"additional","affiliation":[{"name":"1School of Biological Sciences, University of Reading, Reading, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"288","published-online":{"date-parts":[[2022,11,21]]},"reference":[{"key":"2022112112461362900_B1","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1161\/01.RES.0000077012.11088.BC","article-title":"Phenotyping hypertrophy: eschew obfuscation","volume":"92","author":"Dorn","year":"2003","journal-title":"Circ. Res."},{"key":"2022112112461362900_B2","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1002\/ejhf.62","article-title":"Targeting myocardial remodelling to develop novel therapies for heart failure: A position paper from the Working Group on Myocardial Function of the European Society of Cardiology","volume":"16","author":"Tarone","year":"2014","journal-title":"Eur. J. Heart Fail."},{"key":"2022112112461362900_B3","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s001090050275","article-title":"Cellular mechanisms of cardiac hypertrophy","volume":"76","author":"Sugden","year":"1998","journal-title":"J. Mol. Med. (Berl.)"},{"key":"2022112112461362900_B4","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1152\/physrev.00054.2009","article-title":"Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale","volume":"90","author":"Rose","year":"2010","journal-title":"Physiol. Rev."},{"key":"2022112112461362900_B5","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1111\/j.1749-6632.2009.05088.x","article-title":"Extracellular signal-regulated kinase 1\/2 (ERK1\/2) signaling in cardiac hypertrophy","volume":"1188","author":"Kehat","year":"2010","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"2022112112461362900_B6","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1038\/nature07511","article-title":"MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts","volume":"456","author":"Thum","year":"2008","journal-title":"Nature"},{"key":"2022112112461362900_B7","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/nature24676","article-title":"IL-11 is a crucial determinant of cardiovascular fibrosis","volume":"552","author":"Schafer","year":"2017","journal-title":"Nature"},{"key":"2022112112461362900_B8","doi-asserted-by":"publisher","first-page":"6341","DOI":"10.1093\/emboj\/19.23.6341","article-title":"The MEK1-ERK1\/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice","volume":"19","author":"Bueno","year":"2000","journal-title":"EMBO J."},{"key":"2022112112461362900_B9","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1161\/01.CIR.0000127126.73759.23","article-title":"MEK1-ERK2 signaling pathway protects myocardium from ischemic injury in vivo","volume":"109","author":"Lips","year":"2004","journal-title":"Circulation"},{"key":"2022112112461362900_B10","doi-asserted-by":"publisher","first-page":"14074","DOI":"10.1073\/pnas.0610906104","article-title":"Genetic inhibition of cardiac ERK1\/2 promotes stress-induced apoptosis and heart failure but has no effect on hypertrophy in vivo","volume":"104","author":"Purcell","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2022112112461362900_B11","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1161\/CIRCRESAHA.110.231514","article-title":"Extracellular signal-regulated kinases 1 and 2 regulate the balance between eccentric and concentric cardiac growth","volume":"108","author":"Kehat","year":"2011","journal-title":"Circ. Res."},{"key":"2022112112461362900_B12","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/bjc.2017.399","article-title":"Targeting the Raf kinases in human cancer: the Raf dimer dilemma","volume":"118","author":"Durrant","year":"2018","journal-title":"Br. J. Cancer"},{"key":"2022112112461362900_B13","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.phrs.2018.08.013","article-title":"Targeting oncogenic Raf protein-serine\/threonine kinases in human cancers","volume":"135","author":"Roskoski","year":"2018","journal-title":"Pharmacol. Res."},{"key":"2022112112461362900_B14","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1177\/1947601911407323","article-title":"Raf family kinases: old dogs have learned new tricks","volume":"2","author":"Matallanas","year":"2011","journal-title":"Genes Cancer"},{"key":"2022112112461362900_B15","first-page":"243","article-title":"Spatial regulation of ARAF controls the MST2-Hippo pathway","volume":"10","author":"Rauch","year":"2019","journal-title":"Small GTPases"},{"key":"2022112112461362900_B16","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1042\/BCJ20210615","article-title":"Cardiomyocyte BRAF and type 1 RAF inhibitors promote cardiomyocyte and cardiac hypertrophy in mice in vivo","volume":"479","author":"Clerk","year":"2022","journal-title":"Biochem. J."},{"key":"2022112112461362900_B17","doi-asserted-by":"publisher","first-page":"26303","DOI":"10.1074\/jbc.270.44.26303","article-title":"Hypertrophic agonists stimulate the activities of the protein kinases c-Raf and A-Raf in cultured ventricular myocytes","volume":"270","author":"Bogoyevitch","year":"1995","journal-title":"J. Biol. Chem."},{"key":"2022112112461362900_B18","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1093\/cvr\/cvv210","article-title":"Cardiac protein kinases: the cardiomyocyte kinome and differential kinase expression in human failing hearts","volume":"108","author":"Fuller","year":"2015","journal-title":"Cardiovasc. Res."},{"key":"2022112112461362900_B19","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.tcm.2005.06.008","article-title":"Role of raf proteins in cardiac hypertrophy and cardiomyocyte survival","volume":"15","author":"Muslin","year":"2005","journal-title":"Trends Cardiovasc. Med."},{"key":"2022112112461362900_B20","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1042\/CS20210192","article-title":"The anti-cancer drug dabrafenib is not cardiotoxic and inhibits cardiac remodelling and fibrosis in a murine model of hypertension","volume":"135","author":"Meijles","year":"2021","journal-title":"Clin. Sci. (Lond.)"},{"key":"2022112112461362900_B21","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1042\/BCJ20220281","article-title":"PKN2 deficiency leads both to prenatal 'congenital' cardiomyopathy and defective angiotensin II stress responses","volume":"479","author":"Marshall","year":"2022","journal-title":"Biochem. J."},{"key":"2022112112461362900_B22","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/jnr.20703","article-title":"Forebrain-specific knockout of B-raf kinase leads to deficits in hippocampal long-term potentiation, learning, and memory","volume":"83","author":"Chen","year":"2006","journal-title":"J. Neurosci. Res."},{"key":"2022112112461362900_B23","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1161\/hh1301.092687","article-title":"Temporally regulated and tissue-specific gene manipulations in the adult and embryonic heart using a tamoxifen-inducible Cre protein","volume":"89","author":"Sohal","year":"2001","journal-title":"Circ. Res."},{"key":"2022112112461362900_B24","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1161\/HYPERTENSIONAHA.119.14556","article-title":"Redox regulation of cardiac ASK1 (Apoptosis Signal-Regulating Kinase 1) controls p38-MAPK (mitogen-activated protein kinase) and orchestrates cardiac remodeling to hypertension","volume":"76","author":"Meijles","year":"2020","journal-title":"Hypertension"},{"key":"2022112112461362900_B25","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.atherosclerosis.2018.07.019","article-title":"Effect of irradiation and bone marrow transplantation on angiotensin II-induced aortic inflammation in ApoE knockout mice","volume":"276","author":"Patel","year":"2018","journal-title":"Atherosclerosis"},{"key":"2022112112461362900_B26","doi-asserted-by":"publisher","first-page":"4878","DOI":"10.1523\/JNEUROSCI.6262-11.2012","article-title":"Central cardiovascular circuits contribute to the neurovascular dysfunction in angiotensin II hypertension","volume":"32","author":"Capone","year":"2012","journal-title":"J. Neurosci."},{"key":"2022112112461362900_B27","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1161\/01.RES.0000135483.12297.e4","article-title":"Hypertension caused by angiotensin II infusion involves increased superoxide production in the central nervous system","volume":"95","author":"Zimmerman","year":"2004","journal-title":"Circ. Res."},{"key":"2022112112461362900_B28","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1161\/01.RES.0000100665.67510.F5","article-title":"Apoptosis signal-regulating kinase 1 plays a pivotal role in angiotensin II-induced cardiac hypertrophy and remodeling","volume":"93","author":"Izumiya","year":"2003","journal-title":"Circ. Res."},{"key":"2022112112461362900_B29","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1042\/BCJ20210144","article-title":"The insulin receptor family and protein kinase B (Akt) are activated in the heart by alkaline pH and alpha1-adrenergic receptors","volume":"478","author":"Meijles","year":"2021","journal-title":"Biochem. J."},{"key":"2022112112461362900_B30","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12974-018-1090-z","article-title":"Differential effect of angiotensin II and blood pressure on hippocampal inflammation in mice","volume":"15","author":"Iulita","year":"2018","journal-title":"J. Neuroinflammation"},{"key":"2022112112461362900_B31","doi-asserted-by":"publisher","first-page":"e10027","DOI":"10.1371\/journal.pone.0010027","article-title":"ERK1\/2 signaling dominates over RhoA signaling in regulating early changes in RNA expression induced by endothelin-1 in neonatal rat cardiomyocytes","volume":"5","author":"Marshall","year":"2010","journal-title":"PLoS ONE"},{"key":"2022112112461362900_B32","doi-asserted-by":"publisher","first-page":"5913","DOI":"10.1038\/s41598-018-24085-9","article-title":"Refined protocols of tamoxifen injection for inducible DNA recombination in mouse astroglia","volume":"8","author":"Jahn","year":"2018","journal-title":"Sci. Rep."},{"key":"2022112112461362900_B33","doi-asserted-by":"publisher","first-page":"H1671","DOI":"10.1152\/ajpheart.01155.2009","article-title":"Cre-loxP DNA recombination is possible with only minimal unspecific transcriptional changes and without cardiomyopathy in Tg(\u03b1MHC-MerCreMer) mice","volume":"299","author":"Hougen","year":"2010","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"2022112112461362900_B34","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1161\/CIRCRESAHA.116.308139","article-title":"Recounting cardiac cellular composition","volume":"118","author":"Zhou","year":"2016","journal-title":"Circ. Res."},{"key":"2022112112461362900_B35","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.drudis.2013.10.019","article-title":"Binucleation of cardiomyocytes: the transition from a proliferative to a terminally differentiated state","volume":"19","author":"Paradis","year":"2014","journal-title":"Drug Discov. Today"},{"key":"2022112112461362900_B36","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1161\/CIRCRESAHA.115.305043","article-title":"Cardiac mechano-gated ion channels and arrhythmias","volume":"118","author":"Peyronnet","year":"2016","journal-title":"Circ. Res."},{"key":"2022112112461362900_B37","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1161\/CIRCRESAHA.116.304937","article-title":"Mechanotransduction in cardiac hypertrophy and failure","volume":"116","author":"Lyon","year":"2015","journal-title":"Circ. Res."},{"key":"2022112112461362900_B38","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.2174\/092986706777441968","article-title":"Endothelin-1: the yin and yang on vascular function","volume":"13","author":"Marasciulo","year":"2006","journal-title":"Curr. Med. Chem."},{"key":"2022112112461362900_B39","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.mam.2018.07.001","article-title":"Cardiac fibrosis: Cell biological mechanisms, molecular pathways and therapeutic opportunities","volume":"65","author":"Frangogiannis","year":"2019","journal-title":"Mol. Aspects Med."},{"key":"2022112112461362900_B40","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1111\/bph.15013","article-title":"IL-11 in cardiac and renal fibrosis: Late to the party but a central player","volume":"177","author":"Corden","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"2022112112461362900_B41","doi-asserted-by":"publisher","first-page":"e10865","DOI":"10.15252\/emmm.201910865","article-title":"Targeting cardiac fibrosis in heart failure with preserved ejection fraction: mirage or miracle?","volume":"12","author":"Sweeney","year":"2020","journal-title":"EMBO Mol. Med."},{"key":"2022112112461362900_B42","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1002\/1873-3468.14234","article-title":"Fibroblast-mediated intercellular crosstalk in the healthy and diseased heart","volume":"596","author":"Nicin","year":"2022","journal-title":"FEBS Lett."},{"key":"2022112112461362900_B43","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1089\/ars.2012.4550","article-title":"NADPH oxidases in heart failure: poachers or gamekeepers?","volume":"18","author":"Zhang","year":"2013","journal-title":"Antioxid Redox Signal."},{"key":"2022112112461362900_B44","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1124\/pr.112.007203","article-title":"Cardiac alpha1-adrenergic receptors: novel aspects of expression, signaling mechanisms, physiologic function, and clinical importance","volume":"66","author":"O'Connell","year":"2014","journal-title":"Pharmacol. Rev."},{"key":"2022112112461362900_B45","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1007\/s00424-013-1225-0","article-title":"Sex differences in exercise-induced cardiac hypertrophy","volume":"465","author":"Foryst-Ludwig","year":"2013","journal-title":"Pflugers Arch."},{"key":"2022112112461362900_B46","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1161\/CIRCRESAHA.118.312017","article-title":"Metabolic coordination of physiological and pathological cardiac remodeling","volume":"123","author":"Gibb","year":"2018","journal-title":"Circ. Res."},{"key":"2022112112461362900_B47","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1111\/echo.15284","article-title":"Pre-heart failure at 2D- and 3D-speckle tracking echocardiography: a comprehensive review","volume":"39","author":"Singh","year":"2022","journal-title":"Echocardiography"},{"key":"2022112112461362900_B48","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1161\/CIRCULATIONAHA.107.758623","article-title":"Functionally opposing roles of extracellular signal-regulated kinase 1\/2 and p38 mitogen-activated protein kinase in the regulation of cardiac contractility","volume":"118","author":"Szokodi","year":"2008","journal-title":"Circulation"},{"key":"2022112112461362900_B49","doi-asserted-by":"publisher","first-page":"2378","DOI":"10.3390\/ijms20102378","article-title":"Structural and functional changes in the Na(+)\/H(+) Exchanger Isoform 1, Induced by Erk1\/2 phosphorylation","volume":"20","author":"Fliegel","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"2022112112461362900_B50","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s00395-011-0161-4","article-title":"Activated NHE1 is required to induce early cardiac hypertrophy in mice","volume":"106","author":"Mraiche","year":"2011","journal-title":"Basic Res. Cardiol."},{"key":"2022112112461362900_B51","doi-asserted-by":"publisher","first-page":"7783","DOI":"10.1073\/pnas.141224398","article-title":"Raf-1 promotes cell survival by antagonizing apoptosis signal-regulating kinase 1 through a MEK-ERK independent mechanism","volume":"98","author":"Chen","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2022112112461362900_B52","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.1126\/science.1103233","article-title":"Role of the kinase MST2 in suppression of apoptosis by the proto-oncogene product Raf-1","volume":"306","author":"O'Neill","year":"2004","journal-title":"Science"},{"key":"2022112112461362900_B53","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1161\/hh1001.090858","article-title":"Myocardial Akt activation and gender: increased nuclear activity in females versus males","volume":"88","author":"Camper-Kirby","year":"2001","journal-title":"Circ. Res."},{"key":"2022112112461362900_B54","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1161\/hh1001.091864","article-title":"Akt like a woman: gender differences in susceptibility to cardiovascular disease","volume":"88","author":"Sugden","year":"2001","journal-title":"Circ. Res."},{"key":"2022112112461362900_B55","doi-asserted-by":"publisher","first-page":"237","DOI":"10.12688\/f1000research.108761.2","article-title":"On the development of B-Raf inhibitors acting through innovative mechanisms","volume":"11","author":"Pinzi","year":"2022","journal-title":"F1000Res."}],"container-title":["Clinical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/136\/22\/1661\/939730\/cs-2022-0607.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/136\/22\/1661\/939730\/cs-2022-0607.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,21]],"date-time":"2022-11-21T07:46:36Z","timestamp":1669016796000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/clinsci\/article\/136\/22\/1661\/232053\/Cardiomyocyte-BRAF-is-a-key-signalling"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":55,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2022,11,30]]}},"URL":"https:\/\/doi.org\/10.1042\/cs20220607","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2022.09.07.506723","asserted-by":"object"}]},"ISSN":["0143-5221","1470-8736"],"issn-type":[{"value":"0143-5221","type":"print"},{"value":"1470-8736","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,11]]},"published":{"date-parts":[[2022,11]]}}}